MedTrace Logo

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

NCT00516919 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2020-04-02

Study results available
· View outcomes & findings →

Summary

This is a research study designed to examine the effectiveness of an obesity medication (orlistat) given in addition to behavioral weight loss therapy. Participants will be obese monolingual (Spanish-speaking only) men and women.

Conditions

Interventions

DRUG

Xenical + behavioral intervention

120 mg TID; Behavioral weight loss in Spanish

BEHAVIORAL

Behavioral intervention + placebo

Behavioral weight loss treatment in Spanish Placebo TID

Sponsors & Collaborators

  • Donaghue Medical Research Foundation

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Carlos M Grilo, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00516919 on ClinicalTrials.gov